PICC Capital Investment Management logo

PICC Capital Investment Management

Asia, Shanghai, China, Shanghai

Description

PICC Capital Investment Management is a privately owned investment manager.

Investor Profile

PICC Capital Investment Management has backed more than 6 startups, with 0 new investments in the last 12 months alone. The firm has led 3 rounds, about 50% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series Unknown, Series D rounds (top funding stages).
  • Majority of deals are located in China, United States.
  • Strong thematic focus on Biotechnology, Manufacturing, Artificial Intelligence (AI).

Stage Focus

  • Series C (50%)
  • Series Unknown (17%)
  • Series D (17%)
  • Series A (17%)

Country Focus

  • China (83%)
  • United States (17%)

Industry Focus

  • Biotechnology
  • Manufacturing
  • Artificial Intelligence (Ai)
  • Pharmaceutical
  • Health Care
  • Automotive
  • Sensor
  • Electronics
  • Semiconductor
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does PICC Capital Investment Management frequently co-invest with?

CICC
Asia, Beijing, China, Beijing
Co-Investments: 3
China Asset Management
Asia, Beijing, China, Beijing
Co-Investments: 1
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
Tencent
Asia, Guangdong, China, Shenzhen
Co-Investments: 2
CL
Asia, Beijing, China, Beijing
Co-Investments: 2
Forebright Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
5Y Capital
Asia, Shanghai, China, Xuhui
Co-Investments: 2
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 3
CD Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
ABC International
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1

What are some of recent deals done by PICC Capital Investment Management?

Worg Pharmaceuticals

Hangzhou, Zhejiang, China

Worg Pharmaceuticals is a clinical stage biopharmaceutical company developing new treatments for allergies and other diseases.

Biotechnology
Series DDec 22, 2025
Amount Raised: $42,608,794
New Radiomedicine Technology

Chengdu, Sichuan, China

Chengdu New Radiomedicine Technology is a Chinese medical isotopes provider.

BiotechnologyHealth CareManufacturingMedical
Series DOct 9, 2025
Amount Raised: $112,225,573

Atech Automotive Electronics is a company that designs, develops, manufactures, and sells automotive electronic products.

AutomotiveManufacturingSensor
Series CNov 8, 2022
Amount Raised: $68,972,177
ChangXin Memory Technologies

Hefei, Anhui, China

ChangXin Memory Technologies specializes in manufacturing dynamic random-access memory (DRAM) semiconductor products.

ElectronicsManufacturingSemiconductor
Series CFeb 17, 2022
Amount Raised: $1,183,469,301
Tongxin Medical Equipment

Suzhou, Jiangsu, China

Tongxin Medical Equipment is an artificial-heart maker company.

Biotechnology
Series DJan 25, 2022
Amount Raised: $100,000,000
METiS Pharmaceuticals

Hangzhou, Zhejiang, China

METiS Pharmaceuticals is the world's first AI-driven drug formulation company.

Artificial Intelligence (AI)BiopharmaBiotechnologyMedical DevicePharmaceutical
Series ADec 13, 2021
Amount Raised: $86,000,000
Jenscare Biotech

Ningbo, Zhejiang, China

Ningbo Jenscare Scientific is a medical device company.

BiotechnologyHealth Care
Series UnknownMay 28, 2021
XtalPi

Cambridge, Massachusetts, United States

XtalPi is a pharmaceutical technology company that is reinventing drug discovery by enabling dry lab predictions with wet lab validation.

Artificial Intelligence (AI)BiotechnologyPharmaceutical
Series CSep 28, 2020
Amount Raised: $318,800,000

Find More Investors Like PICC Capital Investment Management

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

PICC Capital Investment Management | Pipeseed